IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
The role of sphingosine-1-phosphate in autophagy and related disorders | Cell Death Discovery
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry
First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study | Lupus Science & Medicine
Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
PDF) Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Potent anti‐inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL‐S1P and their impairment in coronary artery disease due to lower HDL‐S1P: a new aspect of HDL dysfunction and its
Whole Blood and Plasma-Based Lipid Profiling Reveals Distinctive Metabolic Changes in Systemic Lupus Erythematosus and Systemic Sclerosis | Journal of Proteome Research
PDF) Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis
Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells - ScienceDirect
Frontiers | Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 | Nature
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 | Nature
First Use of Cenerimod, a Selective sphingosine-1-phosphate 1 (S1P1) Receptor Modulator, for the Treatment of Systemic Lupus Erythematosus: A Double-Blind, Randomised, Placebo-Controlled, Phase II, Proof-of-Concept Study - ACR Meeting Abstracts
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry
IJMS | Free Full-Text | In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P1) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel,
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus | RMD Open
Trends in the Use of Sphingosine 1 Phosphate in Age-Related Diseases: A Scientometric Research Study (1992-2020)
Cells | Free Full-Text | The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus | RMD Open
![Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00138/asset/images/large/jm1c00138_0002.jpeg "Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis ...")
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis ...
Idorsia | Cenerimod
Trends in the Use of Sphingosine 1 Phosphate in Age-Related Diseases: A Scientometric Research Study (1992-2020)
FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice | Circulation
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus | RMD Open
Summary of S1P receptor modulators currently undergoing or completed in... | Download Table
The role of sphingosine-1-phosphate in autophagy and related disorders | Cell Death Discovery
Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome | Arthritis Research & Therapy | Full Text
Frontiers | Competitive Binding of Ozanimod and Other Sphingosine 1-Phosphate Receptor Modulators at Receptor Subtypes 1 and 5
Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect
The structure and function of the S1P1 receptor - ScienceDirect
Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect
Chemical structures of sphingosine 1-phosphate, fingolimod, siponimod... | Download Scientific Diagram
Cells | Free Full-Text | Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 | Nature
Frontiers | The apoM/S1P Complex—A Mediator in Kidney Biology and Disease?
Pharmaceuticals | Free Full-Text | Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis
Therapeutic Modulation of the Interferon Pathway in Systemic Lupus Erythematosus | SpringerLink
Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect
Action mechanism of fingolimod and other S1P receptor modulators.... | Download Scientific Diagram
PDF) First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: A double-blind, randomised, placebo-controlled, proof-of-concept study
Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells
Chemical structures of sphingosine 1-phosphate, fingolimod, siponimod... | Download Scientific Diagram
PDF) 6 Efficacy of cenerimod, a selective S1P1 receptor modulator, in the MRL/lpr mouse model of systemic lupus erythematosus
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology - ScienceDirect
IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
The structure and function of the S1P1 receptor: Trends in Pharmacological Sciences
Frontiers | Competitive Binding of Ozanimod and Other Sphingosine 1-Phosphate Receptor Modulators at Receptor Subtypes 1 and 5
Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect
